Beyond stratum corneum

Dermal Absorption and Toxicity Assessment, Second Edition

Volumn , Issue , 2007, Pages 209-250

  Dancik, Yuri ^a   Jepps, Owen G ^a   Roberts, Michael S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79957782061     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (132)

1. Madison KC. Barrier function of the skin: “La Raison d’Etre” of the epidermis. J Invest Dermatol 2003; 121(2):231-41.
2. McGrath JA, Eady RAJ, Pope FM. Anatomy and organization of human skin. In:Burns T, ed. Rook’s Textbook of Dermatology. Oxford: Blackwell Publishers, 2004.
3. Wang TF, Kasting GB, Nitsche JM. A multiphase microscopic diffusion model for stratum corneum permeability. I. Formulation, solution, and illustrative results for representative compounds. J Pharm Sci 2006; 95(3):620-48.
4. Ritschel WA, Hussain AS. The principles of permeation of substances across the skin. Methods Find Exp Clin Pharmacol 1988; 10(1):39-56.
5. Walters KA, Roberts MS. The structure and function of skin. In:Walters KA, ed. Dermatological and Transdermal Formulations. New York: Marcel Dekker, Inc., 2002;1-39.
6. Jakubovic HR, Ackermann AB. Structure and function of skin: development, morphology, and physiology. In:Moschella SL, Hurley HJ, eds. Dermatology. Philadelphia, PA: W.B. Saunders Company, 1992;3-87.
7. Montagna W, Kligman AM, Carlisle KS. Atlas of Normal Human Skin. New York:Springer, 1992.
8. Grams YY, Bouwstra JA. Penetration and distribution in human skin focusing on the hair follicle. In:Bronaugh RL, Maibach HI, eds. Percutaneous Absorption: Drugs-Cosmetics-Mechanisms-Methods. Boca Raton, FL: Taylor & Francis Group, 2005;177-91.
9. Agarwal R, Katare OP, Vyas SP. The pilosebaceous unit: a pivotal route for topical drug delivery. Methods Find Exp Clin Pharmacol 2000; 22(2):129-33.
10. Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 2004; 122(1):14-9.
11. Pagnoni A, Kligman AM, el Gammal S, Stoudemayer T. Determination of density of follicles on various regions of the face by cyanoacrylate biopsy: correlation with sebum output. Br J Dermatol 1994; 131(6):862-5.
12. Holbrook KA, Odland GF. Regional differences in the thickness (cell layers) of the human stratum corneum: an ultrastructural analysis. J Invest Dermatol 1974; 62(4):415-22.
13. Ya-Xian Z, Suetake T, Tagami H. Number of cell layers of the stratum corneum in normal skin-relationship to the anatomical location on the body, age, sex and physical parameters. Arch Dermatol Res 1999; 291(10):555-9.
14. Scott RC, Corrigan MA, Smith F, Mason H. The influence of skin structure on permeability: an intersite and interspecies comparison with hydrophilic penetrants. J Invest Dermatol 1991; 96(6):921-5.
15. Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev 1971; 51(4):702-47.
16. Schaefer H, Lademann J. The role of follicular penetration. A differential view. Skin Pharmacol Appl Skin Physiol 2001; 14(Suppl. 1):23-7.
17. Odland GF. Structure of the skin. In:Goldsmith LA, ed. Physiology, Morphology and Molecular Biology of the Skin. New York: Oxford University Press, 1991;3-110.
18. Lauer AC. Percutaneous drug delivery to the hair follicle. In:Bronaugh RL, Maibach HI, eds. Percutaneous Absorption: Drugs-Cosmetics-Mechanisms-Methods. Boca Raton, FL: Taylor & Francis, 2005;411-28.
19. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999; 341(7):491-7.
20. Montagna W. The sebaceous gland in man. In:Montagna W, Ellis RA, eds. Advances in Biology of Skin. New York: Pergamn Press, Inc., 1961;19-31.
21. Fawcett DW, Raviola E. Bloom and Fawcett: A Textbook of Histology. 12th ed. New York: Chapman and Hall, 1994.
22. Zouboulis CC. Sebaceous gland in human skin-the fantastic future of a skin appendage. J Invest Dermatol 2003; 120(6)xiv-v.
23. Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol 2004; 22(5):360-6.
24. Meidan VM, Bonner MC, Michniak BB. Transfollicular drug delivery-is it a reality? Int J Pharm 2005; 306(1-2):1-14.
25. Cross SE, Anderson C, Roberts MS. Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies. Br J Clin Pharmacol 1998; 46(1):29-35.
26. Hurley HJ. The eccrine sweat glands: structure and function. In:Freinkel RK, Woodley DT, eds. The Biology of the Skin. New York: Parthenon Publishing Group, 2001;47-76.
27. Sato K, Leidal R, Sato F. Morphology and development of an apoeccrine sweat gland in human axillae. Am J Physiol 1987; 252(1 Pt 2):R166-80.
28. Wilke K, Wepf R, Keil FJ, Wittern K-P, Wenck H, Biel SS. Are sweat glands an alternate penetration pathway? Understanding the morphological complexity of the axillary sweat gland apparatus Skin Pharmacol Physiol 2006; 19(1):38-49.
29. Braverman IM. The cutaneous microcirculation. J Investig Dermatol Symp Proc 2000; 5(1):3-9.
30. Braverman IM, Keh A, Goldminz D. Correlation of laser Doppler wave patterns with underlying microvascular anatomy. J Invest Dermatol 1990; 95(3):283-6.
31. Cevc G, Vierl U. Spatial distribution of cutaneous microvasculature and local drug clearance after drug application on the skin. J Control Release 2007; 118(1):18-26.
32. Ellis RA. Vascular patterns in the skin. In:Montagna W, Ellis RA, eds. Advances in Biology of the Skin. New York: Pergamon Press, Inc., 1961;20-36.
33. O’Driscoll CM. Anatomy and physiology of the lymphatics. In: Charman WN, Stella VJ, eds. Lymphatics Transport of Drugs. Boca Raton, FL: CRC Press, 1992.
34. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001; 14(2):101-14.
35. Hadgraft J. Skin, the final frontier. Int J Pharm 2001; 224(1-2):1-18.
36. Scheuplein RJ. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol 1967; 48(1):79-88.
37. Flynn GL, Yalkowsk Sh. Correlation and prediction of mass-transport across membranes. 1. Influence of alkyl chain-length on flux-determining properties of barrier and diffusant. J Pharm Sci 1972; 61(6):838-52.
38. Roberts MS, Anderson RA, Swarbrick J. Percutaneous absorption of phenolic compounds-mechanism of diffusion across stratum-corneum. J Pharm Pharmacol 1978; 30(8):486-90.
39. Anissimov YG, Roberts MS. Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration. J Pharm Sci 1999; 88(11):1201-9.
40. Wenkers BP, Lippold BC. Skin penetration of nonsteroidal antiinflammatory drugs out of a lipophilic vehicle: influence of the viable epidermis. J Pharm Sci 1999; 88(12):1326-31.
41. Rajaraman G, Roberts MS, Hung D, Wang GQ, Burczynski FJ. Membrane binding proteins are the major determinants for the hepatocellular transmembrane flux of longchain fatty acids bound to albumin. Pharm Res 2005; 22(11):1793-804.
42. Cleek RL, Bunge AL. A new method for estimating dermal absorption from chemical exposure. 1. General approach. Pharm Res 1993; 10(4):497-506.
43. Bunge AL, Cleek RL. A new method for estimating dermal absorption from chemical exposure: 2. Effect of molecular weight and octanol-water partitioning. Pharm Res 1995; 12(1):88-95.
44. Crank J. The Mathematics of Diffusion. Oxford: Oxford University Press, 1975.
45. Guy RH, Hadgraft J. Pharmacokinetic interpretation of the plasma levels of clonidine following transdermal delivery. J Pharm Sci 1985; 74(9):1016-8.
46. Khalil E, Kretsos K, Kasting GB. Glucose partition coefficient and diffusivity in the lower skin layers. Pharm Res 2006; 23(6):1227-34.
47. Baker JR, Christian RA, Simpson P, White AM. The binding of topically applied glucocorticoids to rat skin. Br J Dermatol 1977; 96(2):171-8.
48. Yourick JJ, Koenig ML, Yourick DL, Bronaugh RL. Fate of chemicals in skin after dermal application: does the in vitro skin reservoir affect the estimate of systemic absorption? Toxicol Appl Pharmacol 2004; 195(3):309-20.
49. Siddiqui O, Roberts MS, Polack AE. Percutaneous absorption of steroids: relative contributions of epidermal penetration and dermal clearance. J Pharmacokinet Biopharm 1989; 17(4):405-24.
50. Walter K, Kurz H. Binding of drugs to human skin: influencing factors and the role of tissue lipids. J Pharm Pharmacol 1988; 40(10):689-93.
51. Yagi S, Nakayama K, Kurosaki Y, Higaki K, Kimura T. Factors determining drug residence in skin during transdermal absorption: studies on beta-blocking agents. Biol Pharm Bull 1998; 21(11):1195-201.
52. Cross SE, Magnusson BM, Winckle G, Anissimov Y, Roberts MS. Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J Invest Dermatol 2003; 120(5):759-64.
53. Magnusson BM, Cross SE, Winckle G, Roberts MS. Percutaneous absorption of steroids:determination of in vitro permeability and tissue reservoir characteristics in human skin layers. Skin Pharmacol Physiol 2006; 19(6):336-42.
54. Roberts MS, Cross SE, Anissimov YG. The skin reservoir for topically applied solutes. In:Bronaugh RL, Maibach HI, eds. Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, Methodology. Boca Raton, FL: Taylor & Francis, 2005;213-34.
55. Liu P, Higuchi WI, Song WQ, Kurihara-Bergstrom T, Good WR. Quantitative evaluation of ethanol effects on diffusion and metabolism of beta-estradiol in hairless mouse skin. Pharm Res 1991; 8(7):865-72.
56. Hikima T, Yamada K, Kimura T, Maibach HI, Tojo K. Comparison of skin distribution of hydrolytic activity for bioconversion of beta-estradiol 17-acetate between man and several animals in vitro. Eur J Pharm Biopharm 2002; 54(2):155-60.
57. Sugibayashi K, Hayashi T, Morimoto Y. Simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin after its topical application: the effect of enzyme distribution in skin. J Control Release 1999; 62(1-2):201-8.
58. Boderke P, Schittkowski K, Wolf M, Merkle HP. Modeling of diffusion and concurrent metabolism in cutaneous tissue. J Theor Biol 2000; 204(3):393-407.
59. Bleasby K, Castle JC, Roberts CJ, et al. Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica 2006; 36(10-11):963-88.
60. Randolph GJ, Beaulieu S, Pope M, et al. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc Natl Acad Sci USA 1998; 95(12):6924-9.
61. Smith G, Dawe RS, Clark C, et al. Quantitative real-time reverse transcriptionpolymerase chain reaction analysis of drug metabolizing and cytoprotective genes in psoriasis and regulation by ultraviolet radiation. J Invest Dermatol 2003; 121(2):390-8.
62. Li Q, Kato Y, Sai Y, Imai T, Tsuji A. Multidrug resistance-associated protein 1 functions as an efflux pump of xenobiotics in the skin. Pharm Res 2005; 22(6):842-6.
63. Baron JM, Holler D, Schiffer R, et al. Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol 2001; 116(4):541-8.
64. Zeng H, Chen ZS, Belinsky MG, Rea PA, Kruh GD. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res 2001; 61(19):7225-32.
65. Keppler D, Leier I, Jedlitschky G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 1997; 378(8):787-91.
66. Sprecher E, Bergman R, Sprecher H, et al. Reduced folate carrier (RFC-1) gene expression in normal and psoriatic skin. Arch Dermatol Res 1998; 290(12):656-60.
67. Schiffer R, Neis M, Holler D, et al. Active influx transport is mediated by members of the organic anion transporting polypeptide family in human epidermal keratinocytes. J Invest Dermatol 2003; 120(2):285-91.
68. Schnorr O, Suschek CV, Kolb-Bachofen V. The importance of cationic amino acid transporter expression in human skin. J Invest Dermatol 2003; 120(6):1016-22.
69. Li Q, Tsuji H, Kato Y, Sai Y, Kubo Y, Tsuji A. Characterization of the transdermal transport of flurbiprofen and indomethacin. J Control Release 2006; 110(3):542-56.
70. Schmuth M, Ortegon AM, Mao-Qiang M, Elias PM, Feingold KR, Stahl A. Differential expression of fatty acid transport proteins in epidermis and skin appendages. J Invest Dermatol 2005; 125(6):1174-81.
71. Boury-Jamot M, Sougrat R, Tailhardat M, et al. Expression and function of aquaporins in human skin: is aquaporin-3 just a glycerol transporter? Biochim Biophys Acta 2006; 1758(8)1034-42.
72. Roberts MS, Cross SE. A physiological pharmacokinetic model for solute disposition in tissues below a topical below a topical application site. Pharm Res 1999; 16(9):1392-8.
73. Cross S, Roberts M. Dermal blood flow, lymphatics, and binding as determinants of topical absorption, clearance, and distribution. In:Riviere J, ed. Dermal Absorption Models in Toxicology and Pharmacology. Boca Raton, FL: Taylor & Francis, 2006;251-81.
74. Tozer TN, Rowland M. Introduction to Pharmacokinetics and Pharmacodynamics: the Quantitative Basis of Drug Therapy. Baltimore, MD: Lippincott Williams & Wilkins, 2006; 326.
75. McCarley KD, Bunge AL. Physiologically relevant two-compartment pharmacokinetic models for skin. J Pharm Sci 2000; 89(9):1212-35.
76. Morgan CJ, Renwick AG, Friedmann PS. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol 2003; 148(3):434-43.
77. Gao X, Wientjes MG, Au JL. Use of drug kinetics in dermis to predict in vivo blood concentration after topical application. Pharm Res 1995; 12(12):2012-7.
78. Singh P, Roberts MS. Effects of vasoconstriction on dermal pharmacokinetics and local tissue distribution of compounds. J Pharm Sci 1994; 83(6):783-91.
79. Riviere JE, Sage B, Williams PL. Effects of vasoactive drugs on transdermal lidocaine iontophoresis. J Pharm Sci 1991; 80(7):615-20.
80. Riviere JE, Monteiro-Riviere NA, Inman AO. Determination of lidocaine concentrations in skin after transdermal iontophoresis: effects of vasoactive drugs. Pharm Res 1992; 9(2):211-4.
81. Sugibayashi K, Yanagimoto G, Hayashi T, Seki T, Juni K, Morimoto Y. Analysis of skin disposition of flurbiprofen after topical application in hairless rats. J Control Release 1999; 62(1-2):193-200.
82. Higaki K, Asai M, Suyama T, Nakayama K, Ogawara K, Kimura T. Estimation of intradermal disposition kinetics of drugs: II. Factors determining penetration of drugs from viable skin to muscular layer. Int J Pharm 2002; 239(1-2):129-41.
83. Cross SE, Megwa SA, Benson HAE, Roberts MS. Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application. Pharm Res 1999; 16(3):427-33.
84. Higaki K, Nakayama K, Suyama T, Amnuaikit C, Ogawara K, Kimura T. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. Int J Pharm 2005; 288(2):227-33.
85. Jacobi U, Kaiser M, Sterry W, Lademann J. Kinetics of blood flow after topical application of benzyl nicotinate on different anatomic sites. Arch Dermatol Res 2006; 298(6):291-300.
86. Borg N, Götharson E, Benfeldt E, Groth L, Ståhle L. Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: comparison of the suction blister technique and cutaneous microdialysis. Acta Derm Venereol 1999; 79(4):274-7.
87. Boutsiouki P, Thompson JP, Clough GF. Effects of local blood flow on the percutaneous absorption of the organophosphorus compound malathion: a microdialysis study in man. Arch Toxicol 2001; 75(6):321-8.
88. Wilson TE, Monahan KD, Short DS, Ray CA. Effect of age on cutaneous vasoconstrictor responses to norepinephrine in humans. Am J Physiol Regul Integr Comp Physiol 2004; 287(5):R1230-4.
89. Clough GF, Boutsiouki P, Church MK, Michel CC. Effects of blood flow on the in vivo recovery of a small diffusible molecule by microdialysis in human skin. J Pharmacol Exp Ther 2002; 302(2):681-6.
90. Cross SE, Roberts MS. Targeting local tissues by transdermal application: understanding drug physicochemical properties that best exploit protein binding and blood flow effects. Drug Dev Res 1999; 46(3-4):309-15.
91. McNeill SC, Potts RO, Francoeur ML. Local enhanced topical delivery (LETD) of drugs:does it truly exist? Pharm Res 1992; 9(11):1422-7.
92. Monteiro-Riviere NA, Inman AO, Riviere JE, McNeill SC, Francoeur ML. Topical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculature. Pharm Res 1993; 10(9):1326-31.
93. Cross SE, Wu Z, Roberts MS. The effect of protein binding on the deep tissue penetration and efflux of dermally applied salicylic acid, lidocaine and diazepam in the perfused rat hindlimb. J Pharmacol Exp Ther 1996; 277(1):366-74.
94. Hern S, Stanton AW, Mellor R, Levick JR, Mortimer PS. Control of cutaneous blood vessels in psoriatic plaques. J Invest Dermatol 1999; 113(1):127-32.
95. Hern S, Stanton AW, Mellor RH, Harland CC, Levick JR, Mortimer PS. In vivo quantification of the structural abnormalities in psoriatic microvessels before and after pulsed dye laser treatment. Br J Dermatol 2005; 152(3):505-11.
96. Hern S, Stanton AW, Mellor RH, Harland CC, Levick JR, Mortimer PS. Blood flow in psoriatic plaques before and after selective treatment of the superficial capillaries. Br J Dermatol 2005; 152(1):60-5.
97. Green DJ, Maiorana AJ, Siong JH, et al. Impaired skin blood flow response to environmental heating in chronic heart failure. Eur Heart J 2006; 27(3):338-43.
98. Charkoudian N. Skin blood flow in adult human thermoregulation: how it works, when it does not, and why. Mayo Clin Proc 2003; 78(5):603-12.
99. Kellogg DL, Jr. In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges. J Appl Physiol 2006; 100(5):1709-18.
100. Greenstein D, Gupta NK, Martin P, Walker DR, Kester RC. Impaired thermoregulation in Raynaud’s phenomenon. Angiology 1995; 46(7):603-11.
101. Khan F, Belch JJ. Skin blood flow in patients with systemic sclerosis and Raynaud’s phenomenon: effects of oral 1-arginine supplementation. J Rheumatol 1999; 26(11):2389-94.
102. Littleford RC, Khan F, Belch JJ. Skin perfusion in patients with erythromelalgia. Eur J Clin Invest 1999; 29(7):588-93.
103. Cross SE, Roberts MS. Subcutaneous absorption kinetics and local tissue distribution of interferon and other solutes. J Pharm Pharmacol 1993; 45(7):606-9.
104. Supersaxo A, Hein WR, Steffen H. Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. Pharm Res 1990; 7(2):167-9.
105. Bocci V, Pessina GP, Paulesu L, Nicoletti C. The lymphatic route. VI. Distribution of recombinant interferon-alpha 2 in rabbit and pig plasma and lymph. J Biol Response Mod 1988; 7(4):390-400.
106. Yoshikawa H, Takada K, Muranishi S. Molecular weight-dependent lymphatic transfer of exogenous macromolecules from large intestine of renal insufficiency rats. Pharm Res 1992; 9(9):1195-8.
107. Uren RF. Lymphatic drainage of the skin. Ann Surg Oncol 2004; 11(3 Suppl.):179S-85.
108. Singh P, Roberts MS. Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application. J Pharmacokinet Biopharm 1993; 21(4):337-73.
109. Singh P, Maibach HI, Roberts MS. Site of effects. In:Roberts MS, Walters KA, eds. Dermal Absorption and Toxicity Assessment. New York: Marcel Dekker, 1998;353-70.
110. Lee CM, Maibach HI. Deep percutaneous penetration into muscles and joints. J Pharm Sci 2006; 95(7):1405-13.
111. Lauer AC, Elder JT, Weiner ND. Evaluation of the hairless rat as a model for in vivo percutaneous absorption. J Pharm Sci 1997; 86(1):13-8.
112. Bernard E, Dubois JL, Wepierre J. Importance of sebaceous glands in cutaneous penetration of an antiandrogen: target effect of liposomes. J Pharm Sci 1997; 86(5):573-8.
113. Wu H, Ramachandran C, Weiner ND, Roessler BJ. Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. Int J Pharm 2001; 220(1-2):63-75.
114. Ogiso T, Shiraki T, Okajima K, Tanino T, Iwaki M, Wada T. Transfollicular drug delivery:penetration of drugs through human scalp skin and comparison of penetration between scalp and abdominal skins in vitro. J Drug Target 2002; 10(5):369-78.
115. Grams YY, Whitehead L, Cornwell P, Bouwstra JA. Time and depth resolved visualisation of the diffusion of a lipophilic dye into the hair follicle of fresh unfixed human scalp skin. J Control Release 2004; 98(3):367-78.
116. Grams YY, Whitehead L, Cornwell P, Bouwstra JA. On-line diffusion profile of a lipophilic model dye in different depths of a hair follicle in human scalp skin. J Invest Dermatol 2005; 125(4):775-82.
117. Lademann J, Otberg N, Richter H, et al. Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol 2001; 14(Suppl. 1):17-22.
118. Lademann J, Otberg N, Richter H, et al. Application of a dermatological laser scanning confocal microscope for investigation in skin physiology. Laser Physics 2003; 13(5):756-60.
119. Lademann J, Richter H, Teichmann A, et al. Nanoparticles-an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 2007; 66(2):159-64.
120. Lieb LM, Liimatta AP, Bryan RN, Brown BD, Krueger GG. Description of the intrafollicular delivery of large molecular weight molecules to follicles of human scalp skin in vitro. J Pharm Sci 1997; 86(9):1022-9.
121. Cone EJ. Mechanisms of drug incorporation into hair. Ther Drug Monit 1996; 18(4):438-43.
122. Kelch A, Wessel S, Will T, Hintze U, Wepf R, Wiesendanger R. Penetration pathways of fluorescent dyes in human hair fibres investigated by scanning near-field optical microscopy. J Microsc 2000; 200(Pt 3):179-86.
123. Genina EA, Bashkatov AN, Sinichkin YP, et al. In vitro and in vivo study of dye diffusion into the human skin and hair follicles. J Biomed Opt 2002; 7(3):471-7.
124. Lademann J, Richter H, Schaefer UF, et al. Hair follicles-a long-term reservoir for drug delivery. Skin Pharmacol Physiol 2006; 19(4):232-6.
125. Johnson HL, Maibach HI. Drug excretion in human eccrine sweat. J Invest Dermatol 1971; 56(3):182-8.
126. Jackson RJ, Davis WB. A mathematical approach to the prediction of the rate of penetration of ions in the sweat duct. J Theor Biol 1982; 97(3):481-9.
127. Lademann J, Otberg N, Richter H, et al. Application of optical non-invasive methods in skin physiology: a comparison of laser scanning microscopy and optical coherent tomography with histological analysis. Skin Res Technol 2007; 13(2):119-32.
128. Schmook T, Jacobi U, Lademann J, Worm M, Stockfleth E. Detection of doxorubicin in the horny layer in a patient suffering from palmar-plantar erythrodysaesthesia. Dermatology 2005; 210(3):237-8.
129. Jacobi U, Waibler E, Schulze P, et al. Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome? Ann Oncol 2005; 16(7):1210-1.
130. Zelickson A. Electron microscopic study of epidermal sweat duct. Arch Dermatol 1961; 83(1):106.
131. Hashimoto K, Gross BG, Lever WF. The ultrastructure of the skin of human embryos. I. The intraepidermal eccrine sweat duct. J Invest Dermatol 1965; 45(3):139-51.
132. Dancik Y, Jepps OG, Roberts MS. Physiologically-based pharmacokinetics and pharmacodynamics of skin. In: Roberts MS, Walters KA, eds. Dermal Absorption and Toxicity Assessment, 2nd ed. New York: Informa Healthcare, Inc. (in press).